insulin
Even with lawsuits and co-pay caps, will Insulin ever be affordable?
The sausage-making of how insulin is priced is not for the faint of heart. I’m a physician, not an economist. But the diagnosis seems plain as day: greed. Once we’ve allowed health care to be an economic entity like mobile phones, sports cars, and jewelry, all players with fingers in the pie will extract as much money from the process as the market will bear. More
The Insulin Wars
Insurance companies and drug manufacturers have come upon an ingenious business plan: They could farm out their dirty work to the doctors and the patients. When there’s an E. coli outbreak that causes illness and death, we rightly expect our regulatory bodies to step in. The outbreak of insulin greed is no different. More
